Makes a mockery of the ODAC process and to even suggest the possibility of a randomised study for children after the discussion around this in the ODAC is uncouth. However they hold the keys to the cabinet. This is a blow to those kids that are suffering. I hope they have some access in the meantime.
So would this be another P3? Hopefully they can convince the FDA of conditional approval with a P4. It's going to be intriguing to see what happens if the C19 ARDS trial results are solid.
Makes a mockery of the ODAC process and to even suggest the...
-
- There are more pages in this discussion • 515 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
98.0¢ |
Change
-0.010(1.01%) |
Mkt cap ! $1.118B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 98.0¢ | $4.720M | 4.751M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 171759 | 98.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.0¢ | 16000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |